Sepio Capital’s Vertex Pharmaceuticals VRTX Stock Holding History

Sepio Capital’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.28M	Buy	8,623 +329	+4%	+$146K	0.22%	62
2026 Q1	$3.7M	Sell	8,294 -571	-6%	-$266K	0.2%	66
2025 Q4	$4.02M	Sell	8,865 -198	-2%	-$85.3K	0.22%	67
2025 Q3	$3.55M	Buy	9,063 +716	+9%	+$299K	0.21%	67
2025 Q2	$3.72M	Sell	8,347 -13	-0.2%	-$5.99K	0.26%	65
2025 Q1	$4.05M	Buy	8,360 +1,311	+19%	+$611K	0.32%	53
2024 Q4	$2.84M	Buy	7,049 +18	+0.3%	+$8.34K	0.23%	81
2024 Q3	$3.27M	Sell	7,031 -64	-0.9%	-$30.7K	0.25%	71
2024 Q2	$3.33M	Sell	7,095 -45	-0.6%	-$19.5K	0.3%	61
2024 Q1	$2.98M	Sell	7,140 -168	-2%	-$71K	0.26%	81
2023 Q4	$2.97M	Sell	7,308 -1,483	-17%	-$548K	0.25%	79
2023 Q3	$3.06M	Buy	8,791 +112	+1%	+$39.2K	0.26%	80
2023 Q2	$3.05M	Sell	8,679 -425	-5%	-$143K	0.25%	110
2023 Q1	$2.87M	Sell	9,104 -2,057	-18%	-$617K	0.26%	112
2022 Q4	$3.22M	Sell	11,161 -2,349	-17%	-$716K	0.28%	95
2022 Q3	$3.91M	Sell	13,510 -1,050	-7%	-$302K	0.39%	81
2022 Q2	$4.1M	Sell	14,560 -5,007	-26%	-$1.34M	0.41%	76
2022 Q1	$5.11M	Sell	19,567 -1,595	-8%	-$379K	0.45%	69
2021 Q4	$4.65M	Buy	21,162 +333	+2%	+$64.8K	0.34%	83
2021 Q3	$3.78M	Buy	+20,829	New	+$4.07M	0.31%	100

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Sepio Capital's VRTX Position: Q2 2026 in Review

Sepio Capital increased its Vertex Pharmaceuticals (VRTX) stake by 4% in Q2 2026, buying an estimated $146K and bringing the position to 8,623 shares worth $4.28M. The position accounts for 0.22% of the portfolio, ranked #62.

Sepio Capital first reported a position in VRTX in Q3 2021 and has held it in 20 quarters since. The position peaked at $5.11M in Q1 2022. 1,761 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

Sepio Capital held 8,623 shares of Vertex Pharmaceuticals worth $4.28M as of Q2 2026.
Sepio Capital bought 329 Vertex Pharmaceuticals shares in Q2 2026, an estimated $146K.
Vertex Pharmaceuticals made up 0.22% of Sepio Capital's portfolio in Q2 2026, its #62 holding.
Sepio Capital first reported a position in Vertex Pharmaceuticals in Q3 2021 and has held it in 20 quarters since.
Sepio Capital's Vertex Pharmaceuticals position peaked at $5.11M in Q1 2022.
1,761 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on Sepio Capital's 13F filing for Q2 2026, filed 28 Jul 2026.